{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:57:33Z","timestamp":1794272253973,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canadian Institutes of Health Research (CIHR) Project Grant","award":["#PJT-168872"],"award-info":[{"award-number":["#PJT-168872"]}]},{"name":"Natural Sciences & Engineering Research Council of Canada (NSERC) Discovery Grant","award":["RGPIN-2025-07078"],"award-info":[{"award-number":["RGPIN-2025-07078"]}]},{"name":"Natural Sciences & Engineering Research Council of Canada (NSERC) Equipment Grant","award":["EQPEQ 440689-13"],"award-info":[{"award-number":["EQPEQ 440689-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04526-8","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:14:53Z","timestamp":1779066893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multitargeted nanoparticles inhibit cancer invasion by disrupting cancer-associated fibroblast-tumor cell crosstalk and modulating collagen pattern and EMT"],"prefix":"10.1186","volume":"24","author":[{"given":"Liting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alradwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar Z.","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Rauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Cescon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"4526_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3892\/ijo.2020.5135","volume":"57","author":"K-A Won","year":"2020","unstructured":"Won K-A, Spruck C. Triple\u2013negative breast cancer therapy: Current and future perspectives (Review). Int J Oncol. 2020;57:1245\u201361. https:\/\/doi.org\/10.3892\/ijo.2020.5135.","journal-title":"Int J Oncol"},{"key":"4526_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019;9:176\u201398. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1177.","journal-title":"Cancer Discov"},{"key":"4526_CR3","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-3045.","journal-title":"Clin Cancer Res"},{"key":"4526_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"R Peto","year":"2012","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012;379:432\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(11)61625-5.","journal-title":"Lancet"},{"key":"4526_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-40146-7","volume-title":"Tumor Microenvironment: Extracellular Matrix Components \u2013 Part A [Internet]","year":"2020","unstructured":"Birbrair A, editor. Tumor Microenvironment: Extracellular Matrix Components \u2013 Part A [Internet]. Cham: Springer International Publishing; 2020. https:\/\/doi.org\/10.1007\/978-3-030-40146-7. [cited 2025 Jan 16]."},{"key":"4526_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","volume":"17","author":"N Erez","year":"2010","unstructured":"Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell. 2010;17:135\u201347. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.041.","journal-title":"Cancer Cell"},{"key":"4526_CR7","first-page":"550","volume":"61","author":"M L\u00f6hr","year":"2001","unstructured":"L\u00f6hr M, Schmidt C, Ringel J, Kluth M, M\u00fcller P, Nizze H, et al. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 2001;61:550\u20135.","journal-title":"Cancer Res"},{"key":"4526_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/sj.bjc.6602141","volume":"91","author":"Y Aoyagi","year":"2004","unstructured":"Aoyagi Y, Oda T, Kinoshita T, Nakahashi C, Hasebe T, Ohkohchi N, et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br J Cancer. 2004;91:1316\u201326. https:\/\/doi.org\/10.1038\/sj.bjc.6602141.","journal-title":"Br J Cancer"},{"key":"4526_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med [Internet] Nat Publishing Group. 2023;55:1322\u201332. https:\/\/doi.org\/10.1038\/s12276-023-01013-0. [cited 2025 Oct 27];.","journal-title":"Exp Mol Med [Internet] Nat Publishing Group"},{"key":"4526_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov Nat Publishing Group. 2019;18:99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1.","journal-title":"Nat Rev Drug Discov Nat Publishing Group"},{"key":"4526_CR11","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1002\/cam4.3014","volume":"9","author":"H Liu","year":"2020","unstructured":"Liu H, Yang Z, Lu W, Chen Z, Chen L, Han S, et al. Chemokines and chemokine receptors: A new strategy for breast cancer therapy. Cancer Med. 2020;9:3786\u201399. https:\/\/doi.org\/10.1002\/cam4.3014.","journal-title":"Cancer Med"},{"key":"4526_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol Nat Publishing Group. 2021;18:792\u2013804. https:\/\/doi.org\/10.1038\/s41571-021-00546-5.","journal-title":"Nat Rev Clin Oncol Nat Publishing Group"},{"key":"4526_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22:159. https:\/\/doi.org\/10.1186\/s12943-023-01860-5.","journal-title":"Mol Cancer"},{"key":"4526_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12:86. https:\/\/doi.org\/10.1186\/s13045-019-0770-1.","journal-title":"J Hematol Oncol"},{"key":"4526_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol Nat Publishing Group. 2002;3:349\u201363. https:\/\/doi.org\/10.1038\/nrm809.","journal-title":"Nat Rev Mol Cell Biol Nat Publishing Group"},{"key":"4526_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fcell.2019.00060","volume":"7","author":"T Liu","year":"2019","unstructured":"Liu T, Zhou L, Li D, Andl T, Zhang Y. Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment. Front Cell Dev Biol. 2019;7:60. https:\/\/doi.org\/10.3389\/fcell.2019.00060.","journal-title":"Front Cell Dev Biol"},{"key":"4526_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40170-020-00221-w","volume":"8","author":"EA Brett","year":"2020","unstructured":"Brett EA, Sauter MA, Machens H-G, Duscher D. Tumor-associated collagen signatures: pushing tumor boundaries. Cancer Metab. 2020;8:14. https:\/\/doi.org\/10.1186\/s40170-020-00221-w.","journal-title":"Cancer Metab"},{"key":"4526_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ijc.33985","volume":"151","author":"R Shi","year":"2022","unstructured":"Shi R, Zhang Z, Zhu A, Xiong X, Zhang J, Xu J, et al. Targeting type I collagen for cancer treatment. Int J Cancer. 2022;151:665\u201383. https:\/\/doi.org\/10.1002\/ijc.33985.","journal-title":"Int J Cancer"},{"key":"4526_CR19","doi-asserted-by":"publisher","first-page":"jcs227116","DOI":"10.1242\/jcs.227116","volume":"132","author":"B Bayarmagnai","year":"2019","unstructured":"Bayarmagnai B, Perrin L, Esmaeili Pourfarhangi K, Gra\u00f1a X, T\u00fczel E, Gligorijevic B. Invadopodia-mediated ECM degradation is enhanced in the G1 phase of the cell cycle. J Cell Sci. 2019;132:jcs227116. https:\/\/doi.org\/10.1242\/jcs.227116.","journal-title":"J Cell Sci"},{"key":"4526_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/stem.1556","volume":"32","author":"Y Kinugasa","year":"2014","unstructured":"Kinugasa Y, Matsui T, Takakura N. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment. Stem Cells. 2014;32:145\u201356. https:\/\/doi.org\/10.1002\/stem.1556.","journal-title":"Stem Cells"},{"key":"4526_CR21","doi-asserted-by":"publisher","unstructured":"Zhang T, Fu C, Alradwan I, Yen T, Lip H, Cai P et al. Targeting Signaling Pathways of Hyaluronic Acid and Integrin Receptors by Synergistic Combination Nanocomposites Inhibits Systemic Metastases and Primary Triple Negative Breast Cancer. Advanced Therapeutics [Internet]. 2021 [cited 2024 July 12];4:2100022. https:\/\/doi.org\/10.1002\/adtp.202100022","DOI":"10.1002\/adtp.202100022"},{"key":"4526_CR22","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","volume":"15","author":"BP Toole","year":"2009","unstructured":"Toole BP. Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin Cancer Res. 2009;15:7462\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0479.","journal-title":"Clin Cancer Res"},{"key":"4526_CR23","doi-asserted-by":"publisher","first-page":"563818","DOI":"10.1155\/2015\/563818","volume":"2015","author":"JM Cyphert","year":"2015","unstructured":"Cyphert JM, Trempus CS, Garantziotis S. Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology. Int J Cell Biol. 2015;2015:563818. https:\/\/doi.org\/10.1155\/2015\/563818.","journal-title":"Int J Cell Biol"},{"key":"4526_CR24","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s11095-006-0282-x","volume":"23","author":"HL Wong","year":"2006","unstructured":"Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z, et al. A New Polymer\u2013Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells. Pharm Res. 2006;23:1574\u201385. https:\/\/doi.org\/10.1007\/s11095-006-0282-x.","journal-title":"Pharm Res"},{"key":"4526_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13346-014-0210-2","volume":"5","author":"D Shan","year":"2015","unstructured":"Shan D, Li J, Cai P, Prasad P, Liu F, Rauth AM, et al. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of \u03b1v\u03b23 integrin-overexpressing breast cancer cells. Drug Deliv Transl Res. 2015;5:15\u201326. https:\/\/doi.org\/10.1007\/s13346-014-0210-2.","journal-title":"Drug Deliv Transl Res"},{"key":"4526_CR26","doi-asserted-by":"publisher","first-page":"102445","DOI":"10.1016\/j.mtbio.2025.102445","volume":"35","author":"I Alradwan","year":"2025","unstructured":"Alradwan I, Zhi P, Zetrini AE, Wang L, He C, Rezaeifarimani M, et al. Empowering chemotherapy-induced antitumor immunity by multi-targeted synergistic combination nanomedicine for triple-negative breast cancer. Mater Today Bio. 2025;35:102445. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102445.","journal-title":"Mater Today Bio"},{"key":"4526_CR27","doi-asserted-by":"publisher","first-page":"2100022","DOI":"10.1002\/adtp.202100022","volume":"4","author":"T Zhang","year":"2021","unstructured":"Zhang T, Fu C, Alradwan I, Yen T, Lip H, Cai P, et al. Targeting Signaling Pathways of Hyaluronic Acid and Integrin Receptors by Synergistic Combination Nanocomposites Inhibits Systemic Metastases and Primary Triple Negative Breast Cancer. Adv Ther. 2021;4:2100022. https:\/\/doi.org\/10.1002\/adtp.202100022.","journal-title":"Adv Ther"},{"key":"4526_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jconrel.2024.11.061","volume":"377","author":"I Alradwan","year":"2025","unstructured":"Alradwan I, Zhi P, Zhang T, Lip H, Zetrini A, He C, et al. Nanoparticulate drug combination inhibits DNA damage repair and PD-L1 expression in BRCA-mutant and wild type triple-negative breast cancer. J Controlled Release. 2025;377:661\u201374. https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.061.","journal-title":"J Controlled Release"},{"key":"4526_CR29","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/ijc.32857","volume":"146","author":"KMH Vangangelt","year":"2020","unstructured":"Vangangelt KMH, Green AR, Heemskerk IMF, Cohen D, van Pelt GW, Sobral-Leite M, et al. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer. Int J Cancer. 2020;146:2296\u2013304. https:\/\/doi.org\/10.1002\/ijc.32857.","journal-title":"Int J Cancer"},{"key":"4526_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.36740\/WLek202103201","volume":"74","author":"LM Zakhartseva","year":"2021","unstructured":"Zakhartseva LM, Yanovytska MA, PROGNOSTIC VALUE OF TUMOR, STROMA RATIO IN TRIPLE NEGATIVE BREAST CANCER. Wiad Lek. 2021;74:565\u201371.","journal-title":"Wiad Lek"},{"key":"4526_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer Nat Publishing Group. 2020;20:174\u201386. https:\/\/doi.org\/10.1038\/s41568-019-0238-1.","journal-title":"Nat Rev Cancer Nat Publishing Group"},{"key":"4526_CR32","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","volume":"39","author":"S Affo","year":"2021","unstructured":"Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell Elsevier. 2021;39:866\u2013e88211. https:\/\/doi.org\/10.1016\/j.ccell.2021.03.012.","journal-title":"Cancer Cell Elsevier"},{"key":"4526_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrc727","volume":"2","author":"JD Hood","year":"2002","unstructured":"Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer Nat Publishing Group. 2002;2:91\u2013100. https:\/\/doi.org\/10.1038\/nrc727.","journal-title":"Nat Rev Cancer Nat Publishing Group"},{"key":"4526_CR34","doi-asserted-by":"publisher","unstructured":"Ludwig BS, Kessler H, Kossatz S, Reuning U, Ludwig BS, Kessler H et al. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field. Cancers [Internet]. publisher; 2021 [cited 2025 Dec 15];13. https:\/\/doi.org\/10.3390\/cancers13071711","DOI":"10.3390\/cancers13071711"},{"key":"4526_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ng1001-117","volume":"29","author":"R Derynck","year":"2001","unstructured":"Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 2001;29:117\u201329. https:\/\/doi.org\/10.1038\/ng1001-117.","journal-title":"Nat Genet"},{"key":"4526_CR36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12964-023-01264-4","volume":"21","author":"S Li","year":"2023","unstructured":"Li S, Sampson C, Liu C, Piao H, Liu H-X. Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities. Cell Communication Signal. 2023;21:266. https:\/\/doi.org\/10.1186\/s12964-023-01264-4.","journal-title":"Cell Communication Signal"},{"key":"4526_CR37","doi-asserted-by":"publisher","first-page":"30765","DOI":"10.1074\/jbc.M000039200","volume":"275","author":"J Yue","year":"2000","unstructured":"Yue J, Mulder KM. Requirement of Ras\/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway. J Biol Chem. 2000;275:30765\u201373. https:\/\/doi.org\/10.1074\/jbc.M000039200.","journal-title":"J Biol Chem"},{"key":"4526_CR38","doi-asserted-by":"publisher","first-page":"289243","DOI":"10.1155\/2012\/289243","volume":"2012","author":"T Gui","year":"2012","unstructured":"Gui T, Sun Y, Shimokado A, Muragaki Y. The Roles of Mitogen-Activated Protein Kinase Pathways in TGF-\u03b2-Induced Epithelial-Mesenchymal Transition. J Signal Transduct. 2012;2012:289243. https:\/\/doi.org\/10.1155\/2012\/289243.","journal-title":"J Signal Transduct"},{"key":"4526_CR39","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.3390\/cancers12103071","volume":"12","author":"KA Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska KA, Katanaev VL. The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis. Cancers (Basel). 2020;12:3071. https:\/\/doi.org\/10.3390\/cancers12103071.","journal-title":"Cancers (Basel)"},{"key":"4526_CR40","doi-asserted-by":"publisher","first-page":"E1291","DOI":"10.1073\/pnas.1220580110","volume":"110","author":"M Gil","year":"2013","unstructured":"Gil M, Seshadri M, Komorowski MP, Abrams SI, Kozbor D. Targeting CXCL12\/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases. Proc Natl Acad Sci U S A. 2013;110:E1291\u20131300. https:\/\/doi.org\/10.1073\/pnas.1220580110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4526_CR41","doi-asserted-by":"publisher","first-page":"e819","DOI":"10.1038\/cddis.2013.364","volume":"4","author":"K Fuchs","year":"2013","unstructured":"Fuchs K, Hippe A, Schmaus A, Homey B, Sleeman JP, Orian-Rousseau V. Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44. Cell Death Dis Nat Publishing Group. 2013;4:e819\u2013819. https:\/\/doi.org\/10.1038\/cddis.2013.364.","journal-title":"Cell Death Dis Nat Publishing Group"},{"key":"4526_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/jcp.20572","volume":"207","author":"G Lisignoli","year":"2006","unstructured":"Lisignoli G, Cristino S, Piacentini A, Cavallo C, Caplan AI, Facchini A. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54. J Cell Physiol. 2006;207:364\u201373. https:\/\/doi.org\/10.1002\/jcp.20572.","journal-title":"J Cell Physiol"},{"key":"4526_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Translational Med. 2019;17:309. https:\/\/doi.org\/10.1186\/s12967-019-2058-1.","journal-title":"J Translational Med"},{"key":"4526_CR44","doi-asserted-by":"publisher","first-page":"112213","DOI":"10.1016\/j.cellsig.2025.112213","volume":"138","author":"X Li","year":"2026","unstructured":"Li X, Han H, Li S, Yang K, Yang Z, Ma L, et al. Cancer-associated fibroblasts: The Achilles\u2019 Heel in thyroid tumor progression and therapy. Cell Signal. 2026;138:112213. https:\/\/doi.org\/10.1016\/j.cellsig.2025.112213.","journal-title":"Cell Signal"},{"key":"4526_CR45","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3390\/polym13162642","volume":"13","author":"R Naomi","year":"2021","unstructured":"Naomi R, Ridzuan PM, Bahari H. Current Insights into Collagen Type I. Polym (Basel). 2021;13:2642. https:\/\/doi.org\/10.3390\/polym13162642.","journal-title":"Polym (Basel)"},{"key":"4526_CR46","doi-asserted-by":"publisher","first-page":"27239","DOI":"10.1074\/jbc.M116.756247","volume":"291","author":"R Nigdelioglu","year":"2016","unstructured":"Nigdelioglu R, Hamanaka RB, Meliton AY, O\u2019Leary E, Witt LJ, Cho T, et al. Transforming Growth Factor (TGF)-\u03b2 Promotes de Novo Serine Synthesis for Collagen Production. J Biol Chem. 2016;291:27239\u201351. https:\/\/doi.org\/10.1074\/jbc.M116.756247.","journal-title":"J Biol Chem"},{"key":"4526_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/cells9020375","volume":"9","author":"MMG Hillege","year":"2020","unstructured":"Hillege MMG, Galli Caro RA, Offringa C, de Wit GMJ, Jaspers RT, Hoogaars WMH. TGF-\u03b2 Regulates Collagen Type I Expression in Myoblasts and Myotubes via Transient Ctgf and Fgf-2 Expression. Cells. 2020;9:375. https:\/\/doi.org\/10.3390\/cells9020375.","journal-title":"Cells"},{"key":"4526_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/cancers10060199","volume":"10","author":"RL Furler","year":"2018","unstructured":"Furler RL, Nixon DF, Brantner CA, Popratiloff A, Uittenbogaart CH. TGF-\u03b2 Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction. Cancers (Basel). 2018;10:199. https:\/\/doi.org\/10.3390\/cancers10060199.","journal-title":"Cancers (Basel)"},{"key":"4526_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03642-z","volume":"5","author":"L Perrin","year":"2022","unstructured":"Perrin L, Belova E, Bayarmagnai B, T\u00fczel E, Gligorijevic B. Invadopodia enable cooperative invasion and metastasis of breast cancer cells. Commun Biol Nat Publishing Group. 2022;5:1\u201314. https:\/\/doi.org\/10.1038\/s42003-022-03642-z.","journal-title":"Commun Biol Nat Publishing Group"},{"key":"4526_CR50","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41467-017-01556-7","volume":"8","author":"DO Velez","year":"2017","unstructured":"Velez DO, Tsui B, Goshia T, Chute CL, Han A, Carter H, et al. 3D collagen architecture induces a conserved migratory and transcriptional response linked to vasculogenic mimicry. Nat Commun Nat Publishing Group. 2017;8:1651. https:\/\/doi.org\/10.1038\/s41467-017-01556-7.","journal-title":"Nat Commun Nat Publishing Group"},{"key":"4526_CR51","doi-asserted-by":"publisher","first-page":"100891","DOI":"10.1016\/j.tranon.2020.100891","volume":"14","author":"Q Li","year":"2021","unstructured":"Li Q, Li M, Zheng K, Tang S, Ma S. Expression pattern analysis and drug differential sensitivity of cancer-associated fibroblasts in triple-negative breast cancer. Transl Oncol. 2021;14:100891. https:\/\/doi.org\/10.1016\/j.tranon.2020.100891.","journal-title":"Transl Oncol"},{"key":"4526_CR52","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.ajpath.2010.11.076","volume":"178","author":"MW Conklin","year":"2011","unstructured":"Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol. 2011;178:1221\u201332. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.076.","journal-title":"Am J Pathol"},{"key":"4526_CR53","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.7150\/thno.55921","volume":"11","author":"G Xi","year":"2021","unstructured":"Xi G, Guo W, Kang D, Ma J, Fu F, Qiu L, et al. Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients. Theranostics. 2021;11:3229\u201343. https:\/\/doi.org\/10.7150\/thno.55921.","journal-title":"Theranostics"},{"key":"4526_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15:34. https:\/\/doi.org\/10.1186\/s13045-022-01252-0.","journal-title":"J Hematol Oncol"},{"key":"4526_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","volume":"15","author":"Z Mai","year":"2024","unstructured":"Mai Z, Lin Y, Lin P, Zhao X, Cui L. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy. Cell Death Dis. 2024;15:307. https:\/\/doi.org\/10.1038\/s41419-024-06697-4.","journal-title":"Cell Death Dis"},{"key":"4526_CR56","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Transl Oncol. 2020;13:100773. https:\/\/doi.org\/10.1016\/j.tranon.2020.100773.","journal-title":"Transl Oncol"},{"key":"4526_CR57","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/bjc.2013.768","volume":"110","author":"Y Yu","year":"2014","unstructured":"Yu Y, Xiao C-H, Tan L-D, Wang Q-S, Li X-Q, Feng Y-M. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signalling. Br J Cancer. 2014;110:724\u201332. https:\/\/doi.org\/10.1038\/bjc.2013.768.","journal-title":"Br J Cancer"},{"key":"4526_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.matbio.2009.12.003","volume":"29","author":"D Medici","year":"2010","unstructured":"Medici D, Nawshad A. Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1. Matrix Biol. 2010;29:161\u20135. https:\/\/doi.org\/10.1016\/j.matbio.2009.12.003.","journal-title":"Matrix Biol"},{"key":"4526_CR59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309\u201322. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.022.","journal-title":"Cancer Cell"},{"key":"4526_CR60","doi-asserted-by":"publisher","first-page":"201272","DOI":"10.1016\/j.humgen.2024.201272","volume":"40","author":"P Garg","year":"2024","unstructured":"Garg P, Jallepalli VR, Verma S. Unravelling the CXCL12\/CXCR4 Axis in breast cancer: Insights into metastasis, microenvironment interactions, and therapeutic opportunities. Hum Gene. 2024;40:201272. https:\/\/doi.org\/10.1016\/j.humgen.2024.201272.","journal-title":"Hum Gene"},{"key":"4526_CR61","doi-asserted-by":"publisher","first-page":"1623137","DOI":"10.3389\/fimmu.2025.1623137","volume":"16","author":"AF Hassan","year":"2025","unstructured":"Hassan AF, Kheraldine H, Abujamous L, Al-Thawadi H, Elhissi A. Inflammation-associated drug resistance and tumor growth in TNBC. Front Immunol. 2025;16:1623137. https:\/\/doi.org\/10.3389\/fimmu.2025.1623137.","journal-title":"Front Immunol"},{"key":"4526_CR62","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12951-025-03217-0","volume":"23","author":"T Liao","year":"2025","unstructured":"Liao T, Chen X, Qiu F, Zhang X, Wu F, Zhao Z, et al. Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review. J Nanobiotechnol. 2025;23:166. https:\/\/doi.org\/10.1186\/s12951-025-03217-0.","journal-title":"J Nanobiotechnol"},{"key":"4526_CR63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"Mol Cancer"},{"key":"4526_CR64","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.1038\/s41598-025-89882-5","volume":"15","author":"NG Ciavattone","year":"2025","unstructured":"Ciavattone NG, Bevoor A, Farfel A, Rehman A, Ho KKY, Rock EC, et al. Inhibiting CXCR4 reduces immunosuppressive effects of myeloid cells in breast cancer immunotherapy. Sci Rep Nat Publishing Group. 2025;15:5204. https:\/\/doi.org\/10.1038\/s41598-025-89882-5.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"4526_CR65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14:54. https:\/\/doi.org\/10.1186\/s40164-025-00647-2.","journal-title":"Exp Hematol Oncol"},{"key":"4526_CR66","doi-asserted-by":"publisher","unstructured":"Han W, Chen S, Yuan W, Fan Q, Tian J, Wang X et al. Oriented collagen fibers direct tumor cell intravasation. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2016;113:11208\u201313. https:\/\/doi.org\/10.1073\/pnas.1610347113","DOI":"10.1073\/pnas.1610347113"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04526-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04526-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T22:28:18Z","timestamp":1783895298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04526-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4526"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04526-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}